The Liberatory Maneuver for the Treatment of Benign Paroxysmal Positional Vertigo (BPPV)
NCT01008124 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2021-03-29
Summary
This study is being done because the investigators would like to know how effective the Liberatory maneuver is in treating benign paroxysmal positional vertigo (BPPV).
Conditions
- Vertigo
- Vestibular Disease
Interventions
- OTHER
-
Liberatory Maneuver
3 cycles of the liberatory maneuver initial session.
- OTHER
-
Placebo maneuver
3 cycles placebo maneuver initial session.
Sponsors & Collaborators
- collaborator OTHER
-
Midwestern University
lead OTHER
Principal Investigators
-
Janet O. Helminski, PhD · Midwestern University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-11-30
- Primary Completion
- 2010-11-30
- Completion
- 2010-11-30
Countries
- United States
Study Locations
More Related Trials
-
Glucocorticosteroid Treatment in Acute Unilateral Vestibulopathy (Vestibular Neuronitis)
NCT05024448 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy Study of A0001 in Subjects With Friedreich's Ataxia
NCT01035671 ·Status: COMPLETED ·Phase: PHASE2
-
A Pivotal Study of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T)
NCT06673056 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study to Evaluate Multiple Ascending Dose and Multi-Dose of DT-216 in Adult Patients With Friedreich Ataxia
NCT05573698 ·Status: COMPLETED ·Phase: PHASE1
-
Lithium in Multiple System Atrophy
NCT00997672 ·Status: TERMINATED ·Phase: PHASE2
-
Amantadine for Improving Neurologic Symptoms in Ataxia-Telangiectasia
NCT00950196 ·Status: COMPLETED ·Phase: PHASE4
-
Memantine Treatment in Fragile X-Associated Tremor/Ataxia Syndrome
NCT00584948 ·Status: COMPLETED ·Phase: NA
-
Effects of Betaserc on Vestibular Compensation in Patients Suffering From Disabling Meniere's Disease and Having Undergone Vestibular Neurotomy
NCT00160238 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Efficacy of Vertistop® D and Vertistop® L in the Prevention of BPPV Recurrence
NCT05748249 ·Status: COMPLETED ·Phase: PHASE1
-
Technical Development of Clinical Laboratory Studies
NCT03253718 ·Status: WITHDRAWN
-
Safety, Efficacy, and Tolerability of NBI-827104 for the Treatment of Essential Tremor
NCT04880616 ·Status: COMPLETED ·Phase: PHASE2
-
Prednisone Treatment for Vestibular Neuronitis
NCT00271791 ·Status: COMPLETED ·Phase: PHASE2
-
Stemchymal® for Polyglutamine Spinocerebellar Ataxia
NCT06397274 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Efficacy of EGb761 in Patients Suffering From Friedreich Ataxia
NCT00824512 ·Status: COMPLETED ·Phase: PHASE2
-
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
NCT00488839 ·Status: COMPLETED ·Phase: PHASE3
-
Vertistop® D and Vertistop® L in Preventing Recurrence of High-recurrence BPPV
NCT04849182 ·Status: COMPLETED ·Phase: NA
-
A Clinical Study to Evaluate the Effect of MIN-102 on the Progression of Friedreich's Ataxia in Male and Female Patients
NCT03917225 ·Status: COMPLETED ·Phase: PHASE2
-
Novel Therapies for Essential Tremor
NCT00018564 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia (FRDA) Patients
NCT00905268 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Oral Treatment MTR-601 in Cervical Dystonia
NCT06830642 ·Status: SUSPENDED ·Phase: PHASE2
-
Safety Study of HPP593 in Subjects During and After Limb Immobilization
NCT01524406 ·Status: TERMINATED ·Phase: PHASE1
-
Four Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Legs Syndrome
NCT00135993 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Pioglitazone Administered to Patients With Friedreich's Ataxia: Proof of Concept
NCT00811681 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Cabergoline Compared With Placebo for the Treatment of RLS
NCT00627003 ·Status: COMPLETED ·Phase: PHASE3
-
An Open Label, Proof of Concept Study to Evaluate the Effects of Dalfampridine Withdrawal on Gait and Balance Parameters in Subjects With Multiple Sclerosis (MS)
NCT01535664 ·Status: COMPLETED